Leap Investments’s Bristol-Myers Squibb BMY Stock Holding History

Leap Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-16,900	Closed	-$857K	–	434
2019 Q3	$857K	Buy	+16,900	New	+$794K	0.43%	74

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Leap Investments's BMY Position: Q4 2019 in Review

Leap Investments sold out of Bristol-Myers Squibb (BMY) in Q4 2019, closing a stake of 16,900 shares — an estimated $857K sold.

Leap Investments first reported a position in BMY in Q3 2019 and held it in 1 quarter. The position peaked at $857K in Q3 2019. 2,218 funds tracked by Wall St. Rank hold BMY as of Q4 2019.

Leap Investments reported no remaining Bristol-Myers Squibb position as of Q4 2019 after selling out during the quarter.
Leap Investments sold 16,900 Bristol-Myers Squibb shares in Q4 2019, an estimated $857K.
Leap Investments first reported a position in Bristol-Myers Squibb in Q3 2019 and held it in 1 quarter.
Leap Investments's Bristol-Myers Squibb position peaked at $857K in Q3 2019.
2,218 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2019.

Based on Leap Investments's 13F filing for Q4 2019, filed 14 Feb 2020.